PLC-XD1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PLC-XD1 monoclonal antibodies for investigating phospholipase C in cellular signaling pathways. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phospholipase C-XD1 catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate, generating inositol trisphosphate and diacylglycerol as second messengers in signal transduction. PLC-XD1 influences numerous physiological processes, including cell proliferation, differentiation, and apoptosis. Research into PLC-XD1 function continues to reveal its significance in cancer and neurodegenerative disorders. Studying PLC-XD1 advances our understanding of fundamental cellular processes and disease mechanisms. Detailed characterization of PLC-XD1 activity provides insights into potential therapeutic targets. The high specificity of Santa Cruz Biotechnology monoclonal antibodies enables researchers worldwide to make meaningful discoveries in cell signaling research.